Вы искали: unblinded (Английский - Эстонский)

unblinded information
katkestatud pimemenetluse teave

following documented radiological progression, patients could be unblinded by the investigator.
pärast radioloogiliselt tõendatud haiguse progresseerumist võis uuringuarst pimendatud ravi avada.

only susars on which the treatment allocation of the subject is unblinded shall be reported by the sponsor.
sponsor teatab tõsisest ettearvamatust kõrvaltoimest ainult juhul, kui katses osalejate ravirühmadesse jaotuse pimemenetlus on katkestatud.

patients who did not meet these criteria were unblinded and the dose was increased by 0.3 mg twice daily.
patsiendid, kes ei vastanud nendele kriteeriumitele, jätkasid ravi avatud uuringus, kus manustatavat annust suurendati 0,3 mg võrra.

oral and intravenous topotecan were associated with similar symptom palliation in patients with relapsed sensitive sclc in patient self reports on an unblinded symptom scale assessment in each of these two studies.
nendes kahes uuringus seostati suukaudset ja intravenoosset topotekaani sarnase sümptomite vähenemisega retsidiveerunud tundliku väikerakk-kopsuvähiga patsientidel nende poolt teatatud sümptomite alusel avatud hindamisskaalal.

however, based on emerging data, the study was unblinded and all hcv genotype 2 subjects continued to receive sofosbuvir and ribavirin for 12 weeks, whilst treatment for
uute andmete ilmnemisel katkestati siiski uuringu pimemenetlus ning kõigile hcv 2. genotüübiga osalejatele jätkati sofosbuviiri ja ribaviriini manustamist 12 nädala jooksul, samas kui

oral and intravenous topotecan were associated with similar symptom palliation in patients with relapsed sensitive sclc in patient self- reports on an unblinded symptom scale assessment in each of these two studies.
nendes kahes uuringus seostati suukaudset ja intravenoosset topotekaani sarnase sümptomite vähenemisega retsidiveerunud, ravile tundliku väikerakk-kopsuvähiga patsientidel nende teatatud sümptomite alusel avatud hindamisskaalal.

after the interim analysis of efficacy and safety, at recommendation of the independent dsmb, the study was unblinded and patients on the placebo arm were offered open-label sunitinib treatment.
pärast vahepealse tõhususe ja ohutuse analüüsi tulemust, muudeti uuring sõltumatu andmeohutuse jälgimise nõukogu (dsmb) soovitusel avatuks ja platseebogrupi patsientidele pakuti avatud menetlusel ravi sunitiniibiga.

one phase 2 study (study 065) and one phase 3 study (study 396) were conducted to evaluate the efficacy of oral topotecan versus intravenous topotecan in patients who had relapsed ≥ 90 days after completion of one prior regimen of chemotherapy. (see table 1) oral and intravenous topotecan were associated with similar symptom palliation in patients with relapsed sensitive sclc in patient self- reports on an unblinded symptom scale assessment in each of these two studies.
nendes kahes uuringus seostati suukaudset ja intravenoosset topotekaani sarnase sümptomite vähenemisega retsidiveerunud tundliku väikerakk- kopsuvähiga patsientidel nende poolt teatatud sümptomite alusel avatud hindamisskaalal.